Trending 
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians to the recall of about 90,000 bottles of Children’s Ibuprofen Oral Suspension in the United States.
In a post on its official X handle on Saturday, the agency said the product was recalled by the United States Food and Drug Administration (FDA) due to the presence of foreign materials.
NAFDAC said the recall was initiated by Strides Pharma Inc., the manufacturer, after reports from consumers of a “gel-like mass” and “black particles” in the medication.
Public Alert No. 028/2026.
Recall of children’s Ibuprofen Oral Suspension in the United States due to potential contamination with foreign material#NAFDACAlertshttps://t.co/016C4j5rxO pic.twitter.com/zH0eGbYDrV— NAFDAC NIGERIA (@NafdacAgency) June 13, 2026
The affected product, Children’s Ibuprofen Oral Suspension USP (100 mg/5 mL), is commonly used to relieve pain from colds, flu, sore throat, headaches, and toothaches in children.
The agency warned that contamination in medicines could affect their safety, quality, and effectiveness.
NAFDAC explained that the recalled batches, produced in India for Taro Pharmaceuticals in the United States, include lot numbers 7261973A and 7261974A and have an expiry date of 31 January 2027.
Although the product was recalled in the US, NAFDAC said it is taking preventive steps to ensure it does not enter the Nigerian market.
The agency has directed its officers nationwide to increase surveillance and remove any affected products if found.
It also advised importers, distributors, healthcare workers, and parents to stay alert and avoid using or selling the affected medicine.
Parents were urged to stop using the product immediately and seek medical help if children experience any unusual reactions.
NAFDAC reaffirmed its commitment to protecting public health through continuous monitoring of medicines in circulation.
